Request / Find a Test Tool

The National Genomic Test Directories specify which genomic tests are commissioned by the NHS in England, to be delivered by Genomic Laboratory Hubs.

This tool allows clinical teams to search all of the genomic tests available to patients through the National Testing Directory. From here you can find out more details about each test and information about how to order them. These tests can only be ordered by clinical teams, if you are a patient looking to request a test please speak to your clinical team directly.

Breast Cancer

Clinical Indication ID & Name

M3

Breast Cancer

Test Group

Solid Tumours (Adult)

Specialties

Test code

M3.2

Test name

Multi-target expression array (Oncotype DX)

Target genes

Multiple - as per proprietary NICE-approved assay

Test scope

Other - Gene Expression

Test method/ technology

Other

Optimal Family Structure

n/a

Eligibility Criteria

As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer

Test code

M3.3

Test name

Multi-target expression array (Endopredict)

Target genes

Multiple - as per proprietary NICE-approved assay

Test scope

Other - Gene Expression

Test method/ technology

Other

Optimal Family Structure

n/a

Eligibility Criteria

As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer

Test code

M3.4

Test name

Multi-target expression array (Prosignia)

Target genes

Multiple - as per proprietary NICE-approved assay

Test scope

Other - Gene Expression

Test method/ technology

Other

Optimal Family Structure

n/a

Eligibility Criteria

As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer

Test code

M3.5

Test name

Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3)

Target genes

NTRK1, NTRK2, NTRK3

Test scope

Structural variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Patient’s clinical status means they are eligible for an NTRK inhibitor in the event an NTRK rearrangement is detected

Test code

M3.6

Test name

Multi-target NGS panel - small variant (PIK3CA)

Target genes

PIK3CA

Test scope

Small variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Molecular assessment will aid diagnosis or management

Test code

M3.7

Test name

DPYD hotspot

Target genes

DPYD

Test scope

Small variant detection

Test method/ technology

Simple targeted mutation testing

Optimal Family Structure

n/a

Eligibility Criteria

Patient planned to receive fluoropyrimidine treatment

Test code

M3.9

Test name

ETV6-NTRK3 FISH/RT-PCR

Target genes

ETV6-NTRK3

Test scope

Structural variant detection

Test method/ technology

FISH/Simple targeted mutation testing

Optimal Family Structure

n/a

Eligibility Criteria

To support testing for suspected secretory carcinoma of the breast. Specialist pathology review indicates that molecular assessment will aid diagnosis or management.

Commissioning group

n/a

Overlapping idications

n/a

Address for samples/request forms

North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH

Supporting documents

Cancer WGS Clinician pack

Education resources

n/a

Service updates

n/a

Request form download

Consent record

See consent guidance in test request form

Sample requirements

See sample guidance in test request form